NRC Health: 3 Key Takeaways for Long-Term Investors
On its third-quarter 2026 earnings call, held on Oct. 27, 2026, NRC Health(NASDAQ:NRC) reported an 11% increase in total recurring contract value, or TRCV, to $151.9 million. That expansion signals steady customer demand for experience management tools even as implementation costs compress near-term profits.
Three things management said stand out.
1. Contract Value Growth Outpaces Revenue as System Implementations Scale
Management held adjusted EBITDA, or earnings before interest, taxes, depreciation, and amortization, margins steady at 27% while funding implementation capacity for major health system contracts. Upfront investments in delivery teams will weigh on short-term profits before contract expansion fuels revenue in the second half of the year.
As planned, we maintain margins, while building the delivery capacity required for the first phase of this multiyear engagement. We continue to expect margin expansion in the second half of the year as revenue increasingly reflects the TRCV growth we have generated.
-- Trent Green, Chief Executive Officer
2. Single-Product Customers Offer a Massive Expansion Opportunity
A vast majority of the company's healthcare clients buy only one solution line, leaving substantial room for contract expansion. Management restructured its sales organization around buyer behavior to sell integrated packages across patient experience measurement, strategic governance, and real-time operational improvement tools.
70% of our customers only buy 1 product from NRC today or roughly I think it might be I think it might be 71% of our customers or something buy only 1 product.
-- Trent Green, Chief Executive Officer
3. Sales Pipeline Grew 60% Amid Competitor Merger Disruption
Industry consolidation created market noise as rivals Qualtrics and Press Ganey merged, prompting some healthcare system buyers to pause ongoing vendor evaluations. NRC Health capitalized on the market uncertainty by boosting sales meeting activity 35% year over year and expanding its deal pipeline.
Our pipeline generation has been strong. Our pipeline is up 60% higher than it was the same quarter last year.
-- Trent Green, Chief Executive Officer
Looking Ahead
Customer meeting activity is accelerating as health systems seek operational stability, and NRC Health's deep domain focus creates a distinct edge. Decades of interconnected patient and employee data provide a structural advantage that generic software models can't match.
No other organization can offer our laser focus this breadth depth, and longitudinal history of healthcare experience data.
-- Trent Green, Chief Executive Officer
Execution hinges on converting recent contract wins into profitable recurring revenue while deploying cash prudently across internal research, strategic M&A, or mergers and acquisitions, and share buybacks.
We will continue to evaluate the relative attractiveness of internal investment, strategic M&A and share repurchases with the goal of compounding free cash flow per share over time.
-- Shane R. Harrison, Chief Financial Officer
Should you buy stock in Nrc Health right now?
Before you buy stock in Nrc Health, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nrc Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflixmade this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $341,966!* Or when Nvidiamade this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,146,819!*
Now, it's worth noting Stock Advisor's total average return is 852% — a market-crushing outperformance compared to 203% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor , and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of November 8, 2026.
The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy .
NRC Health: 3 Key Takeaways for Long-Term Investors was originally published by The Motley Fool
